MW

Matthew Welsch

BF Biomea Fusion: 7 patents #2 of 36Top 6%
CU Columbia University: 2 patents #655 of 2,492Top 30%
BT Biohaven Therapeutics: 1 patents #21 of 36Top 60%
YU Yale University: 1 patents #732 of 1,662Top 45%
📍 New Haven, CT: #59 of 1,003 inventorsTop 6%
🗺 Connecticut: #3,182 of 34,797 inventorsTop 10%
Overall (All Time): #332,942 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12275739 Inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2025-04-15
12162892 CD16a binding agents and uses thereof Anna BUNIN, Lawrence G. Iben, Douglas Manion, David Spiegel 2024-12-10
12116371 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2024-10-15
12077544 Irreversible inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2024-09-03
11845753 Inhibitors of menin-mll interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2023-12-19
11702421 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2023-07-18
11572370 CD16A binding agents and uses thereof Anna BUNIN, Lawrence G. Iben, Douglas Manion, David Spiegel 2023-02-07
11530198 Compositions and methods for treating infections Stephen B. Thomas, Allen Hopper 2022-12-20
11174263 Inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2021-11-16
11084825 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Thomas Butler, Jim Palmer, Ravi Upasani, Sridhar Vempati, Brendan Kelly +1 more 2021-08-10
10780084 Antibody-recruiting molecules for the treatment of cancer David Spiegel, H. Marie Loughran, Jeffrey Claude Pelletier, Allen B. Reitz 2020-09-22
10774073 Compositions and methods for treating infections Stephen B. Thomas, Allen Hopper 2020-09-15
9926293 Multivalent RAS binding compounds Brent R. Stockwell 2018-03-27
9695133 Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use Brent R. Stockwell, Wan Seok Yang 2017-07-04